(R)-1-(2-Methyl-3-(trifluoromethyl)phenyl)ethan-1-amine, 97%, 250mg

1,2,3,4-Tetrahydrocarbazol-4-one>98.0%(GC)25g

4-Hydroxy-4'-dimethylaminoazobenzene>98.0%(HPLC)(T)25g

Methyl 4-bromo-3-(hydroxymethyl)benzoate, 97%, 250mg

2,2-Dichloroacetamide>98.0%(N)25g

2-Nonenoic Acid>92.0%(GC)25mL

Indolizine-2-carboxylic acid, 95.0%, 10g

methyl tricosanoate, 95.0%, 250mg

ETHYL 4-((3-CHLORO-4-METHOXYBENZYL)AMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXYLATE, 95.0%, 5g

(S)-4-Chloro-3-hydroxybutyronitrile, 95.0%, 25g

Sel de sodium d'héparine, min 180 UI/mg, Ph.Eur., de muqueuse intestinale porcine, 5 g

(2S)-2-[(4-{[(2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid, 98%, 1g

Hydroxypropyl Acrylate (mixture of 2-Hydroxypropyl and 2-Hydroxy-1-methylethyl Acrylate) (stabilized with MEHQ)>90.0%(GC)25mL